Skip to main content
. Author manuscript; available in PMC: 2013 Jan 29.
Published in final edited form as: Neuropsychopharmacology. 2009 Jun 3;34(10):2252–2264. doi: 10.1038/npp.2009.52

Table 2.

Top Ranked SNPs Associated with the FTND in the Treatment Seeking Smoker Cohort

SNP Gene Genomic1 Major2 Minor3 MAF4 Model5 Beta6 SE7 PLRT8 PACT9
rs10891552 DRD2 IVS1+12127 A T 0.04 Add 0.87 0.27 0.0014 0.037
rs2975226 SLC6A3 −2303 T A 0.39 Add 0.31 0.10 0.0029 0.057
rs2652510 SLC6A3 −4547 T C 0.40 Dom 0.45 0.15 0.0026 0.081
rs834829 NR4A2 −14150 G A 0.29 Dom 0.37 0.15 0.0117 0.091
rs2652511 SLC6A3 −3076 G A 0.39 Dom 0.44 0.15 0.0033 0.097
1

Genomic, location of SNP relative to gene.

2

Major, major or referent allele.

3

Minor or variant allele.

4

MAF, minor allele frequency.

5

Models are Additive (Add) and Dominant (Dom).

6

Coefficient of genotype term of GLM model. A positive value implies association of the minor allele with increased FTND.

7

SE, standard error of Beta.

8

Likelihood ratio test P value.

9

P value adjusted for correlated tests.

HHS Vulnerability Disclosure